Skip to main content
Figure 2 | Cardiovascular Diabetology

Figure 2

From: Effects of pitavastatin versus atorvastatin on the peripheral endothelial progenitor cells and vascular endothelial growth factor in high-risk patients: a pilot prospective, double-blind, randomized study

Figure 2

Percentage of stained dual-positive endothelial progenitor cells (EPCs) of gated mononuclear cells analyzed by flow cytometry. There are no differences of (A) CD34+CD133+ EPCs and (B) CD133+KDR+ EPCs between pitavastatin and atorvastatin groups. (C) The levels of circulating CD34+KDR+ EPCs are significantly increased after 12 week treatment with pitavastatin. *: p < 0.05 compared with baseline.

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840